Case studies showing clinical signs and management of cutaneous toxicity of the MEK1/2 inhibitor AZD6244 (ARRY-142886) in patients with solid tumours.
作者信息
Desar Ingrid M E, Bovenschen H Jorn, Timmer-Bonte Anja J N H, Cantarini Mireille V, Van Der Graaf Winette T A, Van Rossum Michelle M, Van Herpen Carla M L
机构信息
Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
出版信息
Acta Oncol. 2010;49(1):110-3. doi: 10.3109/02841860903104152.
PMID:19634052
Abstract
摘要
Zotero 插件